3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Acquired Immunodeficiency Syndrome
2
Sarcoma, Kaposi
1
Opportunistic Infections
1
Inflammation
1
HIV Infections
1
Epstein-Barr Virus Infections
1
Cytomegalovirus Infections
1
Coinfection
1
Interventions
pandemrix
1
lactitol
1
halofantrine
1
focetria
1
Vaccines
1
Ritonavir
1
R-CHOP protocol
1
Nurse Clinicians
1
Lopinavir
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
Emtricitabine
1
Antiretroviral Therapy, Highly Active
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
HIV Infections
×
Ritonavir
×
Clear all
NCT00444379
2014-08-20
ARKS
University of California, San Francisco
Phase 4
Completed
224 enrolled